Left Bundle Branch Area Pacing Versus Biventricular Pacing in Cardiac Resynchronization Therapy: A Systematic Review
Nomesh Kumar1, Akash Kumar2, Shanzay Akhtar3
1From the Department of Medicine, OSF Saint Francis Medical Center, Peoria, IL.
Critical Pathways in Cardiology
|January 14, 2026
Summary
Left bundle branch area pacing (LBBAP) significantly reduces mortality and hospitalizations for cardiac resynchronization therapy (CRT) patients compared to biventricular pacing (BiVP). LBBAP also improves heart function and reduces procedure times.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Technology
Background:
- Left bundle branch area pacing (LBBAP) is an alternative to biventricular pacing (BiVP) for cardiac resynchronization therapy (CRT).
- The physiological targeting of LBBAP offers potential advantages over BiVP.
Purpose of the Study:
- To systematically review and compare the clinical and procedural outcomes of LBBAP versus BiVP in CRT patients.
- To evaluate the impact of LBBAP on mortality, hospitalizations, and cardiac function.
Main Methods:
- A systematic search of major databases (PubMed, Cochrane Central, Embase) was performed.
- Included studies were randomized and observational, comparing LBBAP and BiVP in CRT.
- Meta-analyses used inverse-variance random-effects models to assess outcomes like mortality, LVEF, and QRS duration.
Main Results:
- LBBAP demonstrated significantly lower all-cause mortality (9.9% vs. 13.9%) and HF-related hospitalizations compared to BiVP.
- LBBAP led to greater improvements in LVEF (4.71%) and QRS duration narrowing (-24.60 ms).
- Procedural and fluoroscopy times were significantly shorter with LBBAP.
Conclusions:
- LBBAP is associated with superior clinical outcomes, including reduced mortality and hospitalizations, compared to BiVP for CRT.
- LBBAP offers procedural benefits and enhances cardiac electrical and functional parameters.
- Further large-scale randomized trials are recommended to validate these findings.
Related Concept Videos
Mitral Regurgitation III: Medical Management
686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Dysrhythmias IV: Characteristics of Bradyarrhythmias
788
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788
Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597


